Aspect Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1K Sell
5
-6
-55% -$1.66K ﹤0.01% 566
2026
Q1
$3.25K Hold
11
﹤0.01% 425
2025
Q4
$3K Sell
11
-47
-81% -$12.8K ﹤0.01% 456
2025
Q3
$15.7K Hold
58
0.01% 250
2025
Q2
$16K Buy
58
+57
+5,700% +$15.5K 0.01% 237
2025
Q1
$265 Hold
1
﹤0.01% 583
2024
Q4
$232 Hold
1
﹤0.01% 584
2024
Q3
$221 Hold
1
﹤0.01% 546
2024
Q2
$197 Sell
1
-8
-89% -$1.65K ﹤0.01% 560
2024
Q1
$1.94K Buy
9
+7
+350% +$1.47K ﹤0.01% 454
2023
Q4
$421 Buy
+2
New +$427 ﹤0.01% 510

Other funds holding CME

Aspect Partners's CME Position: Q2 2026 in Review

Aspect Partners reduced its CME Group (CME) stake by 55% in Q2 2026, selling an estimated $1.66K and leaving 5 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Aspect Partners first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $16K in Q2 2025. 342 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Aspect Partners held 5 shares of CME Group worth $1.1K as of Q2 2026.
  • Aspect Partners sold 6 CME Group shares in Q2 2026, an estimated $1.66K.
  • CME Group made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #566 holding.
  • Aspect Partners first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Aspect Partners's CME Group position peaked at $16K in Q2 2025.
  • 342 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.